The DOI matches its Crossref record; 192 of the 192 references it cites were found in a registry or an index.
The ST2/IL-33 Axis in Immune Cells during Inflammatory Diseases
Open accessAbstract
Il1rl1 (also known as ST2) is a member of the IL-1 superfamily, and its only known ligand is IL-33. ST2 exists in two forms as splice variants: a soluble form (sST2), which acts as a decoy receptor, sequesters free IL-33, and does not signal, and a membrane-bound form (ST2), which activates the MyD88/NF-κB signaling pathway to enhance mast cell, Th2, regulatory T cell (Treg), and innate lymphoid cell type 2 functions. sST2 levels are increased in patients with active inflammatory bowel disease, acute cardiac and small bowel transplant allograft rejection, colon and gastric cancers, gut mucosal damage during viral infection, pulmonary disease, heart disease, and graft-versus-host disease. Recently, sST2 has been shown to be secreted by intestinal pro-inflammatory T cells during gut inflammation; on the contrary, protective ST2-expressing Tregs are decreased, implicating that ST2/IL-33 signaling may play an important role in intestinal disease. This review will focus on what is known on its signaling during various inflammatory disease states and highlight potential avenues to intervene in ST2/IL-33 signaling as treatment options.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Williams, H. C., Leung, D. Y. M., Thestrup‐Pedersen, K., & David, T. J. (2000) · Cited by 4,599
Schmitz, J., Owyang, A., Oldham, E., Song, Y., Murphy, E., McClanahan, T. K., Zurawski, G., Moshrefi, M., Qin, J., Li, X., et al. (2005) · Immunity · doi:10.1016/j.immuni.2005.09.015 · Cited by 3,710
Inflammatory links between obesity and metabolic disease
Lumeng, C. N., & Saltiel, A. R. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57132 · Cited by 2,319 · cited 1×
“Obesity and Metabolic Complications Accumulation of visceral adipose tissue (VAT) due to obesity leads to inflammation, insulin resistance, and development of type 2 diabetes (191), leading to the reduction and function of Tregs in the VAT (192), which have been shown to be enriched for ST2 expression (193, 194).”
BackgroundFeuerer, M., Herrero, L., Cipolletta, D., Naaz, A., Wong, J., Nayer, A., Lee, J., Goldfine, A. B., Benoist, C., Shoelson, S., et al. (2009) · Nature Medicine · doi:10.1038/nm.2002 · Cited by 2,145
Innate production of TH2 cytokines by adipose tissue-associated c-Kit+Sca-1+ lymphoid cells
Moro, K., Yamada, T., Tanabe, M., Takeuchi, T., Ikawa, T., Kawamoto, H., Furusawa, J.-I., Ohtani, M., Fujii, H., & Koyasu, S. (2010) · Nature · doi:10.1038/nature08636 · Cited by 1,992
Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity
Neill, D. R., Wong, S. H., Bellosi, A., Flynn, R. J., Daly, M., Langford, T. K. A., Bucks, C., Kane, C. M., Fallon, P. G., Pannell, R., et al. (2010) · Nature · doi:10.1038/nature08900 · Cited by 1,938
Sabatine, M. S., Cannon, C. P., Gibson, C. M., López-Sendón, J. L., Montalescot, G., Theroux, P., Claeys, M. J., Cools, F., Hill, K. A., Skene, A. M., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050522 · Cited by 1,924
Bieber, T. (2008) · New England Journal of Medicine · doi:10.1056/nejmra074081 · Cited by 1,780
Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus
Monticelli (2011) · PubMed · doi:10.1031/ni.2131 · Cited by 1,286
Veldhoen, M., Uyttenhove, C., van Snick, J., Helmby, H., Westendorf, A., Buer, J., Martin, B., Wilhelm, C., & Stockinger, B. (2008) · Nature Immunology · doi:10.1038/ni.1659 · Cited by 1,213
Research works printed but not linked: 10
- Tominaga, 2016, Soluble form of the ST2 gene product exhibits growth promoting activity in NIH-3T3 cells, Biochem Biophys Rep, 5, 8, 10.1016/j.bbrep.2015.11.020 · doi:10.1016/j.bbrep.2015.11.020
- Caselli, 2014, Inflammation in cardiac disease: focus on Interleukin-33/ST2 pathway, Inflamm Cell Signal, 1, e149, 10.14800/ics.149 · doi:10.14800/ics.149
- Diaz-Jimenez, 2011, Soluble ST2: a new and promising activity marker in ulcerative colitis, World J Gastroenterol, 17, 2181, 10.3748/wjg.v17.i17.2181 · doi:10.3748/wjg.v17.i17.2181
- McDonald, 2015, Plasma biomarkers of acute GVHD and nonrelapse mortality: predictive value of measurements before GVHD onset and treatment, Blood, 126, 113, 10.1182/blood-2015-03-636753 · doi:10.1182/blood-2015-03-636753
- Abu Zaid, 2017, Plasma biomarkers of risk for death in a multicenter phase 3 trial with uniform transplant characteristics post-allogeneic HCT, Blood, 129, 162, 10.1182/blood-2016-08-735324 · doi:10.1182/blood-2016-08-735324
- Mathews, 2016, Elevated ST2 distinguishes incidences of pediatric heart and small bowel transplant rejection, Am J Transplant, 16, 938, 10.1111/ajt.13542 · doi:10.1111/ajt.13542
- Lin, 2016, Distribution and clinical association of plasma soluble ST2 during the development of type 2 diabetes, Diabetes Res Clin Pract, 118, 140, 10.1016/j.diabres.2016.06.006 · doi:10.1016/j.diabres.2016.06.006
- Thomassen, 1995, Role of cell type-specific promoters in the developmental regulation of T1, an interleukin 1 receptor homologue, Cell Growth Differ, 6, 179
- Na, 2012, IL-33 enhances Siglec-8 mediated apoptosis of human eosinophils, Cytokine, 57, 169, 10.1016/j.cyto.2011.10.007 · doi:10.1016/j.cyto.2011.10.007
- Seo, 2016, Biomarkers for idiopathic pneumonia syndrome (IPS) after hematopoietic cell transplantation (HCT): comparison with viral infectious pneumonia, Biol Blood Marrow Transplant, 22, S73, 10.1016/j.bbmt.2015.11.366 · doi:10.1016/j.bbmt.2015.11.366
Cited by
The Immunopathophysiology of Endometriosis
Symons, L. K., Miller, J. E., Kay, V. R., Marks, R. M., Liblik, K., Koti, M., & Tayade, C. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.07.004 · Cited by 567
Cardoso, A. L., Fernandes, A., Aguilar-Pimentel, J. A., de Angelis, M. H., Guedes, J. R., Brito, M. A., Ortolano, S., Pani, G., Athanasopoulou, S., Gonos, E. S., et al. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.07.004 · Cited by 475
The family of the interleukin‐1 receptors
Boraschi, D., Italiani, P., Weil, S., & Martin, M. U. (2018) · Immunological Reviews · doi:10.1111/imr.12606 · Cited by 389
Adaptive immunity: an emerging player in the progression of NAFLD
Sutti, S., & Albano, E. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0210-2 · Cited by 374
An immune-based biomarker signature is associated with mortality in COVID-19 patients
Abers, M. S., Delmonte, O. M., Ricotta, E. E., Fintzi, J., Fink, D. L., de Jesus, A. A. A., Zarember, K. A., Alehashemi, S., Oikonomou, V., Desai, J. V., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.144455 · Cited by 340
Cytokine Tuning of Intestinal Epithelial Function
Andrews, C., McLean, M. H., & Durum, S. K. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01270 · Cited by 319
IL33: Roles in Allergic Inflammation and Therapeutic Perspectives
Chan, B. C. L., Lam, C. W. K., Tam, L.-S., & Wong, C. K. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00364 · Cited by 285
Eosinophils: The unsung heroes in cancer?
Varricchi, G., Galdiero, M. R., Loffredo, S., Lucarini, V., Marone, G., Mattei, F., Marone, G., & Schiavoni, G. (2018) · OncoImmunology · doi:10.1080/2162402x.2017.1393134 · Cited by 280
Potential anti-tumor effects of regulatory T cells in the tumor microenvironment: a review
Li, Y., Zhang, C., Jiang, A., Lin, A., Liu, Z., Cheng, X., Wang, W., Cheng, Q., Zhang, J., Wei, T., et al. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05104-y · Cited by 105
“Stimulation of ST2/IL-33 pathway in stable Tregs enhances their quantity and function, while decreasing IL-17 production [113].”
BackgroundElevated Sera sST2 Is Associated With Heart Failure in Men ≤50 Years Old With Myocarditis
Coronado, M. J., Bruno, K. A., Blauwet, L. A., Tschöpe, C., Cunningham, M. W., Pankuweit, S., van Linthout, S., Jeon, E., McNamara, D. M., Krejčí, J., et al. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.118.008968 · Cited by 99
Alarmin cytokines as central regulators of cutaneous immunity
Hasegawa, T., Oka, T., & Demehri, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.876515 · Cited by 70
Bawazeer, M. A., & Theoharides, T. C. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172760 · Cited by 70
Innate Lymphoid Cells Play a Pathogenic Role in Pericarditis
Choi, H. S., Won, T., Hou, X., Chen, G., Bracamonte-Baran, W., Talor, M. V., Jurčová, I., Szárszoi, O., Čurnova, L., Stříž, I., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.02.040 · Cited by 43
Rafi, U., Ahmad, S., Bokhari, S. S., Iqbal, M. A., Zia, A., Khan, M. A., & Roohi, N. (2021) · Mediators of Inflammation · doi:10.1155/2021/3425560 · Cited by 30
Autoimmune Myocarditis: Animal Models
Poli, V., Bruno, K. A., & Fairweather, D. (2020) · Myocarditis · doi:10.1007/978-3-030-35276-9_6 · Cited by 5
Metadata
- Authors
- Griesenauer, B., & Paczesny, S.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2017-04-24
- Volume
- 8
- Pages
- 475-475
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2609744794
- Cited by
- 619
- References
- 192
- FWCI
- 18.84
- Type
- journal article
- Language
- en
- Open access
- gold
- Funders
- National Cancer Institute (R01CA168814)
- National Institute of Diabetes and Digestive and Kidney Diseases (T32DK007519)
- Leukemia and Lymphoma Society (1293-15)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.